ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

LNTH Lantheus Holdings Inc

76.02
0.12 (0.16%)
May 10 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Lantheus Holdings Inc LNTH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.12 0.16% 76.02 23:00:00
Open Price Low Price High Price Close Price Previous Close
76.29 75.2749 76.96 76.02 75.90
more quote information »

Recent News

Date Time Source Heading
5/02/202406:00GLOBELantheus Reports First Quarter 2024 Financial Results
4/18/202407:00GLOBELantheus to Host First Quarter 2024 Earnings Conference Call..
3/11/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202409:46EDGAR2Form 144 - Report of proposed sale of securities
3/05/202419:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202419:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202419:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202419:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202419:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202419:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202418:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202407:30GLOBELantheus to Present at the Leerink Partners Global Biopharma..
3/04/202416:44EDGAR2Form 144 - Report of proposed sale of securities
3/04/202407:30GLOBELantheus Announces the FDA Approval of DEFINITY® (Perflutren..
2/28/202407:30GLOBELantheus Announces Promotion of Amanda Morgan to Chief..
2/26/202407:30GLOBELantheus to Present at the TD Cowen 44th Annual Health Care..
2/22/202406:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/22/202406:47EDGAR2Form 8-K - Current report
2/22/202406:00GLOBELantheus Reports Fourth Quarter and Full Year 2023 Financial..
2/15/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202409:18EDGAR2Form 144 - Report of proposed sale of securities
2/13/202407:30GLOBELantheus Announces Collaboration to Provide Novel Tau..
2/08/202407:00GLOBELantheus to Host Fourth Quarter and Full Year 2023 Earnings..
1/26/202406:59EDGAR2Form 8-K - Current report
1/23/202407:00EDGAR2Form 8-K - Current report
1/23/202406:45GLOBELantheus Announces CEO Succession Plan
1/18/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/16/202411:05EDGAR2Form 144 - Report of proposed sale of securities
1/11/202407:00GLOBELantheus Announces Acceptance of its First-to-File ANDA for..
1/09/202407:00GLOBELantheus Expands Radiopharmaceutical Oncology Pipeline via..
1/09/202406:57EDGAR2Form 8-K - Current report
1/09/202406:55GLOBELantheus Reports Preliminary Fiscal Year 2023 Revenue
1/03/202407:30GLOBELantheus to Present at the 42nd Annual J.P. Morgan..
12/19/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202306:30GLOBELantheus and POINT Biopharma Announce Positive Topline..
12/15/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202310:18EDGAR2Form 144 - Report of proposed sale of securities
12/13/202311:06EDGAR2Form 144 - Report of proposed sale of securities
11/20/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202312:22EDGAR2Form 144 - Report of proposed sale of securities
11/15/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/15/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:45EDGAR2Form 144 - Report of proposed sale of securities